205 related articles for article (PubMed ID: 15531510)
1. Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells.
Ding L; Xu J; Luo X; Chegini N
J Clin Endocrinol Metab; 2004 Nov; 89(11):5549-57. PubMed ID: 15531510
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin-releasing hormone and TGF-beta activate MAP kinase and differentially regulate fibronectin expression in endometrial epithelial and stromal cells.
Luo X; Ding L; Chegini N
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E991-E1001. PubMed ID: 15265761
[TBL] [Abstract][Full Text] [Related]
3. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling.
Levens E; Luo X; Ding L; Williams RS; Chegini N
Mol Hum Reprod; 2005 Jul; 11(7):489-94. PubMed ID: 16123076
[TBL] [Abstract][Full Text] [Related]
4. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
Luo X; Levens E; Williams RS; Chegini N
Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
[TBL] [Abstract][Full Text] [Related]
5. Differential expression, regulation, and induction of Smads, transforming growth factor-beta signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and alteration by gonadotropin-releasing hormone analog.
Xu J; Luo X; Chegini N
J Clin Endocrinol Metab; 2003 Mar; 88(3):1350-61. PubMed ID: 12629129
[TBL] [Abstract][Full Text] [Related]
6. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells.
Luo X; Ding L; Chegini N
Mol Hum Reprod; 2006 Apr; 12(4):245-56. PubMed ID: 16571622
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
[TBL] [Abstract][Full Text] [Related]
8. Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy.
Luo X; Ding L; Xu J; Williams RS; Chegini N
Endocrinology; 2005 Mar; 146(3):1074-96. PubMed ID: 15604208
[TBL] [Abstract][Full Text] [Related]
9. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro.
Chegini N; Rong H; Dou Q; Kipersztok S; Williams RS
J Clin Endocrinol Metab; 1996 Sep; 81(9):3215-21. PubMed ID: 8784072
[TBL] [Abstract][Full Text] [Related]
10. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
[TBL] [Abstract][Full Text] [Related]
11. microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells.
Pan Q; Luo X; Chegini N
Mol Hum Reprod; 2010 Mar; 16(3):215-27. PubMed ID: 19906824
[TBL] [Abstract][Full Text] [Related]
12. Gonadotropin releasing hormone analogue therapy alters signal transduction pathways involving mitogen-activated protein and focal adhesion kinases in leiomyoma.
Chegini N; Kornberg L
J Soc Gynecol Investig; 2003 Jan; 10(1):21-6. PubMed ID: 12517589
[TBL] [Abstract][Full Text] [Related]
13. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy.
Dou Q; Zhao Y; Tarnuzzer RW; Rong H; Williams RS; Schultz GS; Chegini N
J Clin Endocrinol Metab; 1996 Sep; 81(9):3222-30. PubMed ID: 8784073
[TBL] [Abstract][Full Text] [Related]
14. Activation of the luteinizing hormone beta promoter by gonadotropin-releasing hormone requires c-Jun NH2-terminal protein kinase.
Yokoi T; Ohmichi M; Tasaka K; Kimura A; Kanda Y; Hayakawa J; Tahara M; Hisamoto K; Kurachi H; Murata Y
J Biol Chem; 2000 Jul; 275(28):21639-47. PubMed ID: 10787426
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta.
Luo X; Ding L; Xu J; Chegini N
Endocrinology; 2005 Mar; 146(3):1097-118. PubMed ID: 15604209
[TBL] [Abstract][Full Text] [Related]
16. MEK/ERK pathway mediates cell-shape-dependent plasminogen activator inhibitor type 1 gene expression upon drug-induced disruption of the microfilament and microtubule networks.
Samarakoon R; Higgins PJ
J Cell Sci; 2002 Aug; 115(Pt 15):3093-103. PubMed ID: 12118065
[TBL] [Abstract][Full Text] [Related]
17. Activation of the p38 mitogen-activated protein kinase pathway by gonadotropin-releasing hormone.
Roberson MS; Zhang T; Li HL; Mulvaney JM
Endocrinology; 1999 Mar; 140(3):1310-8. PubMed ID: 10067858
[TBL] [Abstract][Full Text] [Related]
18. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta.
Lee BS; Nowak RA
J Clin Endocrinol Metab; 2001 Feb; 86(2):913-20. PubMed ID: 11158066
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway.
Hocevar BA; Brown TL; Howe PH
EMBO J; 1999 Mar; 18(5):1345-56. PubMed ID: 10064600
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of mitogen-activated protein kinase by gonadotropin-releasing hormone in human granulosa-luteal cells.
Kang SK; Tai CJ; Nathwani PS; Choi KC; Leung PC
Endocrinology; 2001 Feb; 142(2):671-9. PubMed ID: 11159838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
